A new treatment for hip osteoarthritis: clinical evidence for the efficacy of autologous conditioned serum
Open Access
- 7 June 2013
- journal article
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 5 (2) , e13-64
Abstract
The purpose of the present study was to investigate the effect of intra-articular injections of autologous conditioned serum on human hip osteoarthritis and to test whether a potential treatment effect might be increased by additional injections of steroids and the recombinant interleukin-1 receptor antagonist protein anakinra. We compared the effects of autologous conditioned serum 46 hip osteoarthritis patients), autologous conditioned serum+cortisone (56 patients), and autologous conditioned serum+cortisone+recombinant interleukin-1 receptor antagonist protein (17 patients) in a retrospective clinical study by means of the Visual Analogue Scale for pain (pre- vs post-treatment). Over 14 months, treatment resulted in a large, statistically significant improvement for patients in all three groups, independent of the severity of osteoarthritis. Neither cortisone nor cortisone+recombinant interleukin-1 receptor antagonist protein increased the beneficial treatment effect over and above the effect of autologous conditioned serum alone. Autologous conditioned serum successfully reduces pain in hip osteoarthritis. In severe hip osteoarthritis, the sole application of autologous conditioned serum can be even more beneficial than the combination of autologous conditioned serum with steroids.Keywords
This publication has 28 references indexed in Scilit:
- A 13-week, multicenter, randomized, double-blind study of lumiracoxib in hip osteoarthritisClinical Rheumatology, 2011
- Effect of hyaluronic acid in symptomatic hip osteoarthritis: A multicenter, randomized, placebo‐controlled trialArthritis & Rheumatism, 2009
- Clinical Responses to Gene Therapy in Joints of Two Subjects with Rheumatoid ArthritisHuman Gene Therapy, 2009
- Neufassung der Empfehlungen der Kommission Pharmakotherapie der DGRhZeitschrift für Rheumatologie, 2007
- Is interleukin-1 a good target for therapeutic intervention in intervertebral disc degeneration: lessons from the osteoarthritic experienceArthritis Research & Therapy, 2007
- Novel Biological Approaches to the Intra-Articular Treatment of OsteoarthritisBioDrugs, 2005
- Is Placebo Surgery Unethical?New England Journal of Medicine, 2002
- In Vivo Transfer of Interleukin-1 Receptor Antagonist Gene in Osteoarthritic Rabbit Knee JointsThe American Journal of Pathology, 1999
- An Evaluation of Internal-Mammary-Artery Ligation by a Double-Blind TechnicNew England Journal of Medicine, 1959
- Radiological Assessment of Osteo-ArthrosisAnnals of the Rheumatic Diseases, 1957